Wockhardt
1,816.70
+59.60(+3.39%)
Market Cap₹28,550.30 Cr
PE Ratio-
IndustryHealthcare
Company Performance:
1D+3.39%
1M+0.71%
6M+32.90%
1Y+116.35%
5Y+692.42%
View Company Insightsright
More news about Wockhardt
29May 25
Wockhardt Narrows Q4 Loss, Reports 6% Revenue Growth
Wockhardt reported a consolidated net loss of ₹45.00 crore in Q4, significantly lower than the ₹177.00 crore loss in the same quarter last year. Revenue increased by 6% to ₹743.00 crore from ₹701.00 crore. The company's EBITDA turned positive at ₹64.00 crore, indicating improved operational performance. Akhilesh Krishna Gupta was reappointed as an Independent Director for a second five-year term.
08Apr 25
Wockhardt Expands European Presence with New Irish Subsidiary
Wockhardt Ltd's subsidiary, Wockhardt Bio AG, has incorporated a new wholly owned subsidiary in Ireland named Wockhardt Antibiotics (Ireland) Limited. The new entity, established on April 7, 2025, with an initial capital of 100 Euro, aims to strengthen Wockhardt's presence in the European market by channeling antibiotic products across the EU. This strategic move is expected to enhance the company's distribution network and leverage Ireland's favorable business environment as a gateway to Europe.
07Apr 25
Wockhardt to Exit US Generics Business Amid Market Challenges
Wockhardt, a major pharmaceutical company, has decided to exit its US generics business, marking a significant change in its operations. This move comes amid increasing competition and regulatory pressures in the US market. The decision suggests a reassessment of Wockhardt's global strategy and potential reallocation of resources to more profitable segments. The exit may create opportunities for other players in the US generics sector while raising questions about the challenges faced by international pharmaceutical companies in this market.
Wockhardt
1,816.70
+59.60
(+3.39%)
1 Year Returns:+116.35%
Industry Peers
Sun Pharmaceutical
1,682.60
(+0.63%)
Divis Laboratories
6,778.50
(-0.83%)
Cipla
1,484.00
(-0.07%)
Torrent Pharmaceuticals
3,404.90
(+2.74%)
Mankind Pharma
2,696.50
(+4.58%)
Dr Reddys Laboratories
1,250.60
(-0.33%)
Zydus Life Science
968.45
(-1.14%)
Lupin
1,926.10
(+1.66%)
Abbott
34,295.00
(-0.36%)
Aurobindo Pharma
1,138.60
(+1.23%)